The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug Administration ...
Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.
PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...
The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...
ETX Daily Up on MSN21h
New drug for schizophrenics has experts excitedNew drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback